COSACTHEN DIN 02498405
Health Canada record
| Active ingredient(s) | TETRACOSACTIDE 0.25 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 13-Oct-2020 |
| Current status date | 13-Oct-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Dechra Veterinary Products Inc. — licence 102149, currently licensed, last inspection rating C (2025-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TETRACOSACTIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00022381 | CORTROSYN INJ 0.25MG | AMPHASTAR PHARMACEUTICALS, INC. | Powder For Solution | TETRACOSACTIDE 0.25 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23516 | 2020-04-27 | New Drug Submission (NDS) |
International API supply for TETRACOSACTIDE
3 active FDA Drug Master Files.
Request a quote for COSACTHEN